Baughman R P, Sharma O P, Lynch J P
Department of Internal Medicine, University of Cincinnati Medical Center, OH, USA.
Semin Respir Infect. 1998 Sep;13(3):255-73.
Treatment of sarcoidosis is controversial. The clinical expression and natural history of sarcoidosis is variable, and spontaneous remissions occur in up to 60% of patients. The decision to treat (or withhold treatment) is often difficult. Corticosteroids, immunosuppressive/cytotoxic, and immunomodulatory agents are used to treat chronic or progressive sarcoidosis, but prospective, randomized trials assessing efficacy of these agents are lacking. Toxicities associated with therapy may be substantial, particularly when high dosages are used. We review the pharmacologic agents used to treat sarcoidosis, toxicities associated with treatment, and appropriate use and monitoring of these therapeutic modalities.
结节病的治疗存在争议。结节病的临床表现和自然病程各不相同,高达60%的患者会出现自发缓解。决定是否进行治疗(或不治疗)往往很困难。皮质类固醇、免疫抑制/细胞毒性药物以及免疫调节药物被用于治疗慢性或进行性结节病,但缺乏评估这些药物疗效的前瞻性随机试验。治疗相关的毒性可能很大,尤其是在使用高剂量药物时。我们综述了用于治疗结节病的药物、治疗相关的毒性以及这些治疗方式的合理使用和监测。